Kathyrn King, PhD Food and Drug Administration

Dr. King earned her Ph.D. from the Department of Biochemistry and Molecular Biology at the University of Manchester in the UK. Following a post-doc in the Department of Medicine at Cambridge University in the UK, she moved to the US FDA in 2000. At the FDA she is employed as a Staff Scientist/Product Quality Reviewer in the Office of Biotechnology Products, Division of Biotechnology Products Research and Review 1, where she serves as a product quality (CMC) reviewer for recombinant therapeutic protein products and carries out research on epithelial cancers. In addition to her employment at the FDA, Dr. King is a co-leader of the PDA Cell Substrate Task Force, which is currently writing a PDA Technical Report on the Emerging Molecular Methods for Virus Detection and a member of the PDA's Advanced Technologies for Virus Detection Users Interest Group.